EP
LKFT

Eudaimonia Partners’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Eudaimonia Partners’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-17
Closed -$1K – 751
2021
Q1 		$1K Buy
+17
New +$1.57K ﹤0.01% 1551

Other funds holding LKFT

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Eudaimonia Partners's LKFT Position: Q2 2021 in Review

Eudaimonia Partners sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2021, closing a stake of 17 shares — an estimated $1K sold.

Eudaimonia Partners first reported a position in LKFT in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 108 funds tracked by Wall St. Rank hold LKFT as of Q2 2021.

  • Eudaimonia Partners reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Eudaimonia Partners sold 17 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2021, an estimated $1K.
  • Eudaimonia Partners first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Eudaimonia Partners's Lakefront Biotherapeutics American Depositary Shares position peaked at $1K in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2021.

Based on Eudaimonia Partners's 13F filing for Q2 2021, filed 13 Aug 2021.